title: Effect of aging on serum gonadotropin levels in healthy subjects and patients with nonfunctioning pituitary adenomas.
abstract: OBJECTIVE
  Nonfunctioning pituitary adenomas (NFPA), which represent about one-quarter of human pituitary tumors, occur in middle or old age. Determination of gonadotropin levels, which are not expected to be high during the early postmenopause in normal women and which are low in women with NFPA, is important to distinguishing hypogonadal status due to the normal decline of gonadal function from that due to hypothlalamic-pituitary dysfunction. The aim of the study was to verify whether this difference still persists in old subjects, despite the physiological decline of gonadotropins in the last decades of life.
  
  
  METHODS
  The study included 154 healthy subjects (aged 50-104 years) and 47 patients with NFPA (aged 50-80 years). Blood samples were collected after an overnight fast and hormone levels were measured by two immunofluorimetric assays.
  
  
  RESULTS
  In healthy women the highest serum levels of gonadotropins were present in the 50-60 year age group, with a slight but progressive age-associated decrease in serum FSH and LH being observed thereafter. In healthy men serum gonadotropin levels were stable up to 70 years, increased up to 75-85 years and thereafter gradually decreasing. Female patients with NFPA showed levels of gonadotropins which were far lower than controls. Only three patients had levels of both FSH and LH above the 2.5 centile for normal subjects. A high sensitivity and specificity of gonadotropin measurements (about 90%) for the diagnosis of NFPA was observed in female patients aged 50-80 years. In male subjects, a large overlap of gonadotropin values in NFPA and controls, namely over the 50-70 years age range, was observed.
  
  
  CONCLUSIONS
  Our study demonstrates that despite the gradual decline of gonadotropin levels in healthy postmenopsausal women, the reduction of both FSH and LH persists in old patients with NFPA, suggesting that measurement of gonadotropin levels could prove useful in the evaluation of pituitary lesions even in old women. More subtle differences seem to occur in male subjects.
authors.affiliation: Institute of Endocrine Sciences, University of Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Vaninetti
authors.forename: A
authors.initials: A
authors.lastname: Baccarelli
authors.forename: R
authors.initials: R
authors.lastname: Romoli
authors.forename: M
authors.initials: M
authors.lastname: Fanelli
authors.forename: G
authors.initials: G
authors.lastname: Faglia
authors.forename: A
authors.initials: A
authors.lastname: Spada
mesh_terms: D000236:Adenoma / Q000097:blood*; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood*; D012016:Reference Values
chemical_list: D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone